Información de la revista
Original article
Open Access
Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease
Eficacia y seguridad de los antivíricos de acción directa para el VHC en la nefropatía crónica de leve a moderada
Ezequiel Ridruejoa,b,c, Rebeca Garcia-Agudod, Manuel Mendizabalb,c, Sami Aoufi-Rabihe, Vivek Dixitf, Marcelo Silvab,c, Fabrizio Fabrizig,
a Hepatology Section, Department of Medicine, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno “CEMIC”, Ciudad Autonoma de Buenos Aires, Argentina
b Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Provincia de Buenos Aires, Argentina
c Latin American Liver Research, Educational and Awareness Network (LALREAN), Pilar, Provincia de Buenos Aires, Argentina
d Nephrology Department, La Mancha-Centro Hospital, Alcázar de San Juan, Ciudad Real, Spain
e Gastroenterology and Hepatology Department, La Mancha-Centro Hospital, Alcázar de San Juan, Ciudad Real, Spain
f Division of Gastroenterology, Hepatology and Parenteral Nutrition, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
g Division of Nephrology, Maggiore Hospital and IRCCS Foundation, Milano, Italy

Artículo

This article is available in English

Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi
10.1016/j.nefroe.2019.03.014
Nefrologia (English Version). 2020;40:46-52
Idiomas
Nefrología